We are live on ! Find out more
Candriam SCA

Candriam SCA Portfolio holdings

AUM $22.5B Turnover 10.3%
1-Year Est. Return 50.38%
 

Candriam is a Luxembourg asset manager with sustainable investing at its core, run as a subsidiary of New York Life Investments, with Belgian bank Belfius holding a minority stake. It was previously Dexia Asset Management and took the Candriam name in 2014, short for "Conviction AND Responsibility In Asset Management", after New York Life's asset management arm acquired it. Its funds span bonds, stocks, absolute return strategies and asset allocation, and its portfolios exclude controversial weapons, thermal coal and tobacco. In 2021 it bought a majority stake in the European real estate manager Tristan Capital Partners.

This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+50.38%
3 Year Est. Return
+175.97%
5 Year Est. Return
+212.01%
10 Year Est. Return
+804.31%
AUM
$22.5B
AUM Growth
+$301M
Cap. Flow
-$416M
Cap. Flow %
-1.85%
Top 10 Hldgs %
34.05%
Holding
699
New
21
Increased
252
Reduced
270
Closed
51
Avg Time Held
6.2 years
Top 10 Avg Time Held
3.9 years
Top 20 Avg Time Held
3.4 years

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$98.2M
2
META icon
Meta Platforms (Facebook)
META
+$82.9M
3
NOW icon
ServiceNow
NOW
+$70.4M
4
INTC icon
Intel
INTC
+$58.4M
5
CRM icon
Salesforce
CRM
+$54.9M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$102M
2
PANW icon
Palo Alto Networks
PANW
+$102M
3
ABBV icon
AbbVie
ABBV
+$68.9M
4
AMZN icon
Amazon
AMZN
+$57M
5
NVDA icon
NVIDIA
NVDA
+$54.1M

Sector Composition

Rank Sector Weight
1 Technology 41.06%
2 Healthcare 24.01%
3 Financials 9.02%
4 Communication Services 7.08%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BNS icon
476
Scotiabank
BNS
$102B
$2.12M 0.01%
23,199
-867
-4% -$78.1K
2016 Q1
42 quarters
CMC icon
477
Commercial Metals
CMC
$5.99B
$2.08M 0.01%
33,332
– –
2026 Q1
2 quarters
CPRT icon
478
Copart
CPRT
$28.8B
$2.05M 0.01%
74,833
+41,356
+124% +$1.24M
2019 Q1
30 quarters
HEI.A icon
479
HEICO Class A
HEI.A
$33.5B
$2.03M 0.01%
8,875
+1,611
+22% +$402K
2019 Q3
28 quarters
LNN icon
480
Lindsay Corp
LNN
$962M
$2.02M 0.01%
18,001
+14,321
+389% +$1.65M
2023 Q1
14 quarters
ENPH icon
481
Enphase Energy
ENPH
$2.6B
$1.97M 0.01%
59,482
+20,423
+52% +$786K
2026 Q2
1 quarter
MKL icon
482
Markel Group
MKL
$23.7B
$1.96M 0.01%
1,139
– –
2022 Q3
16 quarters
J icon
483
Jacobs Solutions
J
$17.6B
$1.93M 0.01%
14,249
– –
2026 Q2
1 quarter
EFX icon
484
Equifax
EFX
$20.7B
$1.9M 0.01%
13,766
+1,834
+15% +$319K
2014 Q4
47 quarters
MHK icon
485
Mohawk Industries
MHK
$8.19B
$1.89M 0.01%
15,080
-2,844
-16% -$354K
2025 Q3
4 quarters
XYZ icon
486
Block Inc
XYZ
$42.1B
$1.88M 0.01%
25,411
-6,831
-21% -$544K
2018 Q1
34 quarters
GEN icon
487
Gen Digital
GEN
$17.3B
$1.82M 0.01%
82,252
-22,764
-22% -$632K
2019 Q4
27 quarters
HSY icon
488
Hershey
HSY
$35.3B
$1.77M 0.01%
11,167
-1,484
-12% -$261K
2014 Q4
47 quarters
CWT icon
489
California Water Service
CWT
$3.09B
$1.77M 0.01%
+38,010
New +$1.88M
2026 Q3
0 quarters
FDXF icon
490
FedEx Freight
FDXF
$17.7B
$1.76M 0.01%
16,009
+3,238
+25% +$443K
2026 Q2
1 quarter
ITRI icon
491
Itron
ITRI
$4.26B
$1.73M 0.01%
19,974
– –
2025 Q2
5 quarters
MAS icon
492
Masco
MAS
$15.9B
$1.69M 0.01%
24,946
-1,483
-6% -$110K
2015 Q3
44 quarters
JBL icon
493
Jabil
JBL
$23.2B
$1.65M 0.01%
5,730
-348
-6% -$111K
2025 Q2
5 quarters
CRWV icon
494
CoreWeave
CRWV
$22B
$1.62M 0.01%
18,583
+1,954
+12% +$167K
2026 Q1
2 quarters
SO icon
495
Southern Company
SO
$108B
$1.62M 0.01%
19,525
– –
2025 Q4
3 quarters
LYV icon
496
Live Nation Entertainment
LYV
$41.2B
$1.61M 0.01%
9,457
+443
+5% +$79.1K
2020 Q3
24 quarters
RS icon
497
Reliance Inc
RS
$20.3B
$1.6M 0.01%
4,141
+3,466
+513% +$1.37M
2026 Q1
2 quarters
RBLX icon
498
Roblox
RBLX
$33.4B
$1.58M 0.01%
37,262
– –
2024 Q3
8 quarters
NBP icon
499
NovaBridge Biosciences American Depositary Shares
NBP
$96M
$1.55M 0.01%
1,132,563
– –
2025 Q2
5 quarters
XPO icon
500
XPO
XPO
$20.3B
$1.54M 0.01%
8,705
+890
+11% +$175K
2026 Q2
1 quarter

Similar funds

Candriam SCA's Q3 2026 Portfolio in Review

As of Q3 2026, Candriam SCA held 699 positions worth $22.5B, up 1.4% from $22.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Candriam SCA's Q3 2026 filing shows 21 new, 252 increased, 270 reduced and 51 closed positions. Its largest new stake was Zenas BioPharma: 654,833 shares worth $17.7M. The largest sale was Alphabet (Google) Class A, an estimated $102M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2026 buy was Zenas BioPharma: 654,833 shares worth $17.7M.
  • Candriam SCA added most to Abbott in Q3 2026, an estimated $98.2M increase.
  • Candriam SCA's biggest Q3 2026 reduction was Alphabet (Google) Class A, cutting an estimated $102M.
  • Candriam SCA fully exited StoneX in Q3 2026, selling an estimated $46.1M.
  • Candriam SCA's ten largest holdings make up 34% of its $22.5B portfolio in Q3 2026.
  • Candriam SCA opened 21 new positions and closed 51 in Q3 2026.
  • Candriam SCA's portfolio value rose 1.4% quarter-over-quarter to $22.5B.

Based on Candriam SCA's 13F filing for Q3 2026, filed 3 Nov 2026.